Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Двойной диагноз: «депрессия» и «расстройство употребления алкоголя». / Сиволап, Юрий Павлович; Крупицкий, Евгений Михайлович; Менделевич, Владимир Давыдович; Рыбакова, Ксения Валерьевна; Егоров, Алексей Юрьевич; Усов, Григорий Михайловия.
в: ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА, Том 121, № 7, 2021, стр. 135-140.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Двойной диагноз: «депрессия» и «расстройство употребления алкоголя».
AU - Сиволап, Юрий Павлович
AU - Крупицкий, Евгений Михайлович
AU - Менделевич, Владимир Давыдович
AU - Рыбакова, Ксения Валерьевна
AU - Егоров, Алексей Юрьевич
AU - Усов, Григорий Михайловия
PY - 2021
Y1 - 2021
N2 - A combination of depression and alcohol use disorder (AUD) is a typical and most common example of a dual diagnosis at the intersection of general psychiatry and addiction psychiatry. A comorbidity of depression and AUD is more common than it can be brought about by mere coincidence, which might be explained to some extent by the synergetic effect of both diseases, with each of them complicating the course and worsening the prognosis of the other. Treatment protocols for patients with depression and comorbid AUD include antidepressants, specific medications for alcohol dependence, and psychotherapy. The first-line antidepressants in the treatment of patients with a comorbid combination of depression and alcohol use disorder, as in other clinical situations implying use of antidepressants, are selective serotonin reuptake inhibitors (SSRIs). Fluvoxamine has certain advantages over the other SSRIs in the treatment of patients with a depression and comorbid AUD.
AB - A combination of depression and alcohol use disorder (AUD) is a typical and most common example of a dual diagnosis at the intersection of general psychiatry and addiction psychiatry. A comorbidity of depression and AUD is more common than it can be brought about by mere coincidence, which might be explained to some extent by the synergetic effect of both diseases, with each of them complicating the course and worsening the prognosis of the other. Treatment protocols for patients with depression and comorbid AUD include antidepressants, specific medications for alcohol dependence, and psychotherapy. The first-line antidepressants in the treatment of patients with a comorbid combination of depression and alcohol use disorder, as in other clinical situations implying use of antidepressants, are selective serotonin reuptake inhibitors (SSRIs). Fluvoxamine has certain advantages over the other SSRIs in the treatment of patients with a depression and comorbid AUD.
KW - alcohol use disorder
KW - antidepressants
KW - compliance
KW - depression
KW - fluvoxamine
KW - selective serotonin reuptake inhibitors
KW - alcohol use disorder
KW - antidepressants
KW - compliance
KW - depression
KW - fluvoxamine
KW - selective serotonin reuptake inhibitors
UR - http://www.scopus.com/inward/record.url?scp=85115279506&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/93bca50b-76eb-3cd9-95a3-a114f7e81e71/
U2 - 10.17116/jnevro2021121071135
DO - 10.17116/jnevro2021121071135
M3 - статья
VL - 121
SP - 135
EP - 140
JO - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА
JF - ЖУРНАЛ НЕВРОЛОГИИ И ПСИХИАТРИИ ИМ. C.C. КОРСАКОВА
SN - 1997-7298
IS - 7
ER -
ID: 87956068